Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
US6395718B1 · kind B1 · utility
75Cited by
89References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 1998 |
| Grant date | May 28, 2002 |
| Priority date | — |
| Expiry date | Jul 6, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C323/52
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to a method of inhibiting angiogenesis comprising administering a N-Acetylated &agr;-Linked Acidic Dipeptidase (NAALADase) inhibitor to a patient in need thereof, and a pharmaceutical composition comprising an anti-angiogenic effective amount of a NAALADase inhibitor and a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.